TREATMENT PATTERNS AND REAL-LIFE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY CUTANEOUS T-CELL LYMPHOMA: CLINICAL PRACTICE DATA IN SPAIN

被引：0
|
作者：
Ortiz-Romero, P. [1 ]
Pimpinelli, N. [2 ]
Illidge, T. [3 ]
Bagot, M. [4 ]
Waser, N. [5 ]
He, M. [5 ]
Zomas, A. [6 ]
Gavini, F. [6 ]
Trinchese, F. [6 ]
Little, M. [7 ]
Dalal, M. [7 ]
Assaf, C. [8 ]
机构：
[1] Hosp Univ 12 Octubre, Fac Med, Inst I 12, CIBERONC, Madrid, Spain
[2] Univ Florence, Dept Hlth Sci, Florence, Italy
[3] Univ Manchester, Christie Hosp, NIHR Biomed Ctr, Manchester, Lancs, England
[4] Hop St Louis, Polyclin Dermatol, Paris, France
[5] ICON Plc, Real World Evidence Strategy & Analyt, Vancouver, BC, Canada
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Millennium Pharmaceut Inc, Cambridge, MA USA
[8] HELIOS Klinikum Krefeld, Krefeld, Germany
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-276
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [21] Treatment of Refractory Cutaneous T-Cell Lymphoma: A Case History
    Fisher, David C.
    Tawa, Marianne C.
    JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2011, 3 (01) : 38 - 41
  • [22] Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
    Marchi, Enrica
    O'Connor, Owen A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (04) : 227 - 235
  • [23] FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
    Lee, Hyon-Zu
    Kwitkowski, Virginia E.
    Del Valle, Pedro L.
    Ricci, M. Stacey
    Saber, Haleh
    Habtemariam, Bahru A.
    Bullock, Julie
    Bloomquist, Erik
    Shen, Yuan Li
    Chen, Xiao-Hong
    Brown, Janice
    Mehrotra, Nitin
    Dorff, Sarah
    Charlab, Rosane
    Kane, Robert C.
    Kaminskas, Edvardas
    Justice, Robert
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2666 - 2670
  • [24] Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
    Nicolay, Jan P.
    Melchers, Susanne
    Albrecht, Jana D.
    Assaf, Chalid
    Dippel, Edgar
    Stadler, Rudolf
    Wehkamp, Ulrike
    Wobser, Marion
    Zhao, Jing
    Burghaus, Ina
    Schneider, Sven
    Guelow, Karsten
    Goerdt, Sergij
    Schuerch, Christian M.
    Utikal, Jochen S.
    Krammer, Peter H.
    BLOOD, 2023, 142 (09) : 794 - 805
  • [25] Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
    Zinzani, Pier Luigi
    Musuraca, Gerardo
    Tani, Monica
    Stefoni, Vittorio
    Marchi, Enrica
    Fina, Mariapaola
    Pellegrini, Cinzia
    Alinari, Lapo
    Derenzini, Enrico
    de Vivo, Antonio
    Sabattini, Elena
    Pileri, Stefano
    Baccarani, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4293 - 4297
  • [26] Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
    Bodiford, Andrew
    Bodge, Megan
    Talbott, Mahsa S.
    Reddy, Nishitha M.
    ONCOTARGETS AND THERAPY, 2014, 7 : 1971 - 1977
  • [27] A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
    Horwitz, Steven M.
    Feldman, Tatyana A.
    Hess, Brian T.
    Khodadoust, Michael S.
    Kim, Youn H.
    Munoz, Javier
    Patel, Manish R.
    Phillips, Tycel J.
    Smith, Stephen D.
    Smith, Sonali M.
    Wilcox, Ryan A.
    Birrell, Matt R.
    Leeds, Janet M.
    Conley, Pamela B.
    Michelson, Glenn C.
    Coffey, Gregory P.
    Curnutte, John T.
    Hamlin, Paul A.
    BLOOD, 2019, 134
  • [28] Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
    Querfeld, Christiane
    Kuzel, Timothy M.
    Kim, Youn H.
    Porcu, Pierluigi
    Duvic, Madeleine
    Musiek, Amy
    Rook, Alain H.
    Mark, Lawrence A.
    Pinter-Brown, Lauren
    Hamid, Oday
    Lin, Boris
    Bian, Ying
    Boye, Mark
    Day, Jeannette M.
    Rosen, Steven T.
    LEUKEMIA & LYMPHOMA, 2011, 52 (08) : 1474 - 1480
  • [29] Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
    Marchi, Enrica
    Raufi, Alexander G.
    O'Connor, Owen A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (02) : 359 - +
  • [30] Quality of Life in Patients with Cutaneous T-Cell Lymphoma
    Martin-Carrasco, P.
    Morillo-Andujar, M.
    Sendin-Martin, M.
    Conejo-Mir, J.
    ACTAS DERMO-SIFILIOGRAFICAS, 2019, 110 (06): : 511 - 513
12345